FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and virology. Any two E2 encoding nucleic acid molecules have the identity percentage less than 75% in any part of 40 or more unbroken nucleotides. There are also described an infectious viral particle and a composition containing the mentioned expression vector.
EFFECT: what is disclosed is the expression vector containing the nucleic acid molecules coding at least two papillomavirus E2 polypeptides.
34 cl, 3 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VECTORS FOR MULTIPLE GENE EXPRESSION | 2008 |
|
RU2462513C2 |
| MUTANT POLYMERASES OF HEPATITIS B VIRUS | 2012 |
|
RU2625021C2 |
| HYBRIDISATION OF HETEROOLIGOMER MYCOBACTERIAL ANTIGENS | 2015 |
|
RU2695462C2 |
| OPTIMISED EXPRESSION OF HPV 58 L1 IN YEAST | 2004 |
|
RU2370538C2 |
| EXPRESSING VECTOR (VARIANTS) | 1995 |
|
RU2177999C2 |
| NUCLEIC ACID MOLECULE ENCODING HPV 31 L1, EXPRESSION VECTOR, HOST CELL, VIRUS-LIKE PARTICLE AND METHOD OF ITS OBTAINMENT, VACCINE, PHARMACEUTICAL COMPOSITION AND METHODS INVOLVING THEM | 2004 |
|
RU2356943C2 |
| COMPOSITION FOR TREATING HEPATITIS B VIRUS INFECTIONS | 2010 |
|
RU2555346C2 |
| VACCINES AGAINST HPV | 2012 |
|
RU2644201C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
| AVIAN TELOMERASE REVERSE TRANSCRIPTASE | 2007 |
|
RU2415867C2 |
